Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Artie | 2026 | Series A | $12.0M | San Francisco |
| Nocion Therapeutics | 2026 | Series B | $23.0M | Cambridge |
| HeyMilo | 2026 | Seed | $3.9M | New York |
| Safire Technology Group | 2025 | Series Unknown | $2.7M | Washington |
| Novee Security | 2025 | Debt Financing | $10.0M | Tel Aviv |
| Quarry Thera | 2025 | Series A | $32.0M | New Haven |
| Sumble | 2025 | Series A | $30.0M | San Francisco |
| Doorstep AI | 2025 | Seed | $8.0M | New York |
| Semnur Pharmaceuticals | 2025 | Post Ipo Equity | $100.0M | Los Altos |
| Arvinas | 2025 | Post Ipo Equity | Undisclosed | New Haven |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Artie | Series A | $12.0M | San Francisco, United States |
| 52 | Nocion Therapeutics | Series B | $23.0M | Cambridge, United States |
| 53 | HeyMilo | Seed | $3.9M | New York, United States |
| 54 | Safire Technology Group | Series Unknown | $2.7M | Washington, United States |
| 55 | Novee Security | Debt Financing | $10.0M | Tel Aviv, Israel |
| 56 | Quarry Thera | Series A | $32.0M | New Haven, United States |
| 57 | Sumble | Series A | $30.0M | San Francisco, United States |
| 58 | Doorstep AI | Seed | $8.0M | New York, United States |
| 59 | Semnur Pharmaceuticals | Post Ipo Equity | $100.0M | Los Altos, United States |
| 60 | Arvinas | Post Ipo Equity | Undisclosed | New Haven, United States |
Artie is a technology platform that provides real-time data replication and streaming services to synchronize data across systems.
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
HeyMilo is an AI-powered candidate screening platform that enables organizations to screen, interview, and evaluate candidates.
Safire Technology Group manufactures Liquid-to-Solid, Hybrid-State Batteries.
Novee is an AI penetration testing platform designed to protect dynamic environments from machine-speed attackers.
Quarry Thera, a next-generation brachytherapy innovator, is advancing brachytherapy using molecular-glue technology.
Sumble provides a sales intelligence platform that crawls the web for technographic and contact data.
Doorstep AI is an artificial intelligence company that provides centimeter precise delivery drop-off location accuracy.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Alkymi is the first end-to-end solution for turning your private markets data into actionable insights.
Omnichent is an AI-powered customer lifecycle management platform.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Actio Biosciences is a research center that develops drugs for rare diseases.
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
Fireflies.ai is an AI‑powered meeting assistant that records, transcribes, summarizes, and analyzes meetings and conversations.
Cynomi provides an AI platform for automating risk assessments and compliance.
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
AttoTude is a THz interconnect technology company using THz radios to enhance bandwidth for AI and hyperscale data centers.
Page is an AI-powered external relations platform that provides real-time insights to help enterprises navigate government policies, media.
Apex.AI specializes in software systems for robotic and autonomous vehicles.
Neofin is a SaaS company that offers an AI-powered software for B2B payments workflows.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Reibus is a B2B marketplace for buying and selling metals that connects businesses and simplifies metal transactions.
Canaan Partners has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Canaan Partners's top investment sectors include Artificial Intelligence (AI), Biotechnology, B2B, Software, Pharmaceutical. The firm invests across 54 different industry categories.
Among tracked funding rounds, Draig Therapeutics received $140.0M in a Series A round. Canaan Partners's total known invested capital is $3.1B.
Canaan Partners's average investment size is $26.7M across its portfolio of 169 companies.
Recent Canaan Partners portfolio additions include Artie, Nocion Therapeutics, HeyMilo, Safire Technology Group, Novee Security. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors